Unique collaboration
This unique collaboration between the UMCG and ICON results in a purpose-built unit, combining the expertise and infrastructure of an academic hospital and the commercial focus of a renowned clinical research organization. As partners we enhance the quality of early phase studies performed within the UMCG, as well as provide the opportunity for ICON to conduct early phase studies with moderate and severe patients and studies with invasive assessments. Combining knowledge and expertise acts as a catalyst for the rapid, innovative and high-quality development of medicines: healthcare improves research, and research improves healthcare. This will, of course, benefit both research and patient.
Unique collaboration
This unique collaboration between the UMCG and ICON results in a purpose-built unit, combining the expertise and infrastructure of an academic hospital and the commercial focus of a renowned clinical research organization. As partners we enhance the quality of early phase studies performed within the UMCG, as well as provide the opportunity for ICON to conduct early phase studies with moderate and severe patients and studies with invasive assessments. Combining knowledge and expertise acts as a catalyst for the rapid, innovative and high-quality development of medicines: healthcare improves research, and research improves healthcare. This will, of course, benefit both research and patient.
About UMCG
The UMCG is one of the largest hospitals in the Netherlands and is the biggest employer in the North of the Netherlands. As an academic hospital, the UMCG offers clinically advanced medical care for complex conditions. The UMCG has 65 departments and has a broad range of expertise centers for rare diseases. With more than 13.000 employees the UMCG uses knowledge, research and innovative solutions to constantly push the boundaries for a sustainable future of health.
The UMCG works on relevant research topics and offers a broad range of top-notch research facilities and equipment. For example the Particle Therapy Research Center, the Cohort and Biobank Coordination Hub and a partnership with Siemens to jointly develop new medical imaging scanners. Through the work of leading national and international researchers, the UMCG is a pioneering center for medical research. The collective effort of UMCG researchers, collaborating networks and partners allow us to make the next step towards more health years. The Clinical Research Unit contributes to this.
About ICON
The Dutch ICON (formerly PRA Health Sciences) team has a long history in the field of clinical research. It was one of the very first units to conduct Phase I trials and has functioned as a blueprint for clinics around the world due to its unique infrastructure and process design.
Since the acquisition by ICON in July 2021, there has been an even greater impact: the size of the combined company and joint expertise makes ICON a global leader in healthcare intelligence and clinical research. ICON plays an important role in the development and innovation in the field of Health Sciences in the Netherlands. ICON’s mission is to help clients accelerate the development of drugs and devices that save lives and improve quality of life. The CRU Groningen contributes to this.
Contact Us
Do you have questions about the CRU Groningen, or do you want to use the unit?